David Scadden
Director · AGIOS PHARMACEUTICALS, INC.
- 2024
- Jun 23, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Scadden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sarah Gheuens - $1.55M in AGIO purchases and sales in the last 12 months
- Brian Goff - $1.18M in AGIO purchases and sales in the last 12 months
- James William Burns - $265K in AGIO purchases and sales in the last 12 months
- Cecilia Jones - $255K in AGIO purchases and sales in the last 12 months
- Theodore James Washburn Jr. - $217K in AGIO purchases and sales in the last 12 months
- Tsveta Milanova - $196K in AGIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Scadden?
David Scadden is a corporate insider, tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David Scadden last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 8 filings going back to 2024.
Has David Scadden been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($98K) across all tracked filings.
